Table 2.

Susceptibility prevalence for Bacillus spp isolates (mm)

Strain	Ribogrup	Cefuroxime	Methicillin	Ceftazidime	Ciprofloxacin	Gentamicin	Amikacin	Vancomycin	Gatifloxacin	Lomefloxacin	Moxifloxacin
B. cereus KA 17.4	EcoRI-114-S-4	R	R	R	30	26	23	20	29	29	31
B.cereus KA 17.8	EcoRI-114-S-4	R	R	R	22	28	23	17	29	27	27
B. cereus PCA 17.2	EcoRI-114-S-4	11	R	13	27	26	23	19	28	33	32
B.cereus KA 17.11	EcoRI-114-S-4	7	R	13	40	36	25	20	30	33	34
B. cereus PCA 15.3	EcoRI-114-S-4	13	R	11	37	22	24	21	33	33	31
B. cereus KA 17.10	EcoRI-114-S-4	13	R	13	33	34	32	22	39	32	37
B. cereus PCA 15.5-2	EcoRI-114-S-4	R	R	10	36	29	41	24	37	24	43
B. cereus KA17.7-1	EcoRI-114-S-4	R	R	12	35	22	24	20	30	32	32
B. cereus KA 49.2	EcoRI-114-S-8	R	R	10	17	32	41	20	25	30	17
B. cereus KA 22.3	EcoRI-114-S-4	11	12	R	36	35	33	24	38	35	37
B.cereus PCA 15.4-1	EcoRI-114-S-4	12	R	R	50	25	41	21	28	27	40
B. cereus PCA 7.2	EcoRI-114-S-4	11	R	R	30	22	20	19	37	40	32
B.cereus KA 52 H(+)	EcoRI-114-S-8	R	10	22	34	16	22	20	36	15	28
B. cereus KA 17.6-1	EcoRI-126-S-8	39	15	31	R	R	28	48	51	R	R
B. pumilus PCA 35.1	EcoRI-122-S-2	12	9	R	30	31	29	21	40	33	43
B.pumilus KA 40	EcoRI-122-S-2	13	21	28	34	21	39	42	43	30	45
B. pumilus PCA 31	EcoRI-122-S-2	15	13	R	30	25	22	16	35	27	43
B. pumilus PCA 36.1	EcoRI-122-S-2	42	14	24	32	58	34	49	38	36	40
B. pumilus PCA 36.2	EcoRI-122-S-2	40	15	25	32	56	35	48	38	37	39
B. pumilus KA 17.5 -2	EcoRI-122-S-2	R	R	R	29	22	32	23	35	30	33
B. pumilus KA 17.5 -1	EcoRI-122-S-2	R	10	R	29	23	33	23	36	31	32
B. pumilus PCA 39.3	EcoRI-122-S-2	12	R	R	34	22	22	21	34	32	33
B. pumilus PCA 4.2	EcoRI-129-S-4	25	R	R	27	25	31	36	18	37	40
B. pumilus PCA 9.4	EcoRI-129-S-4	14	R	R	36	20	26	27	40	33	38
B.mojevensis PCA 34.1	EcoRI-114-S-2	30	15	15	25	39	55	31	35	R	37
B.mojevensis PCA 24.1	EcoRI-114-S-2	R	R	10	31	50	26	19	31	40	38
B. subtilis PCA 11.2- 1	EcoRI-129-S-1	36	19	28	35	24	24	22	36	30	R